Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMG

/PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological...

Related Keywords

Jerusalem ,Israel General ,Israel ,Germany ,Saxony ,Sachsen ,Berlin ,German ,Amos Gilhar ,Scinai Bioservices ,Amir Reichman ,Scinai Nanoabs ,Tamar Ben Yedidia ,Scinai Immunotherapeutics ,Dermatology Drug Development Summit Europe ,Business Development ,Dermatology Drug Development ,Prnewswire Scinai Immunotherapeutics Ltd ,European Dermatology Forum ,Nasdaq ,German Dermatological Society ,University Medical Center ,Company Contacts ,Scinai Immunotherapeutics Ltd ,Department Of Dermatology ,Route Of Administration Formulations ,Hotel Palace Berlin ,Lower Saxony Institute Of Occupational Dermatology ,Chief Science Officer ,Michael Sch ,Skin Research Laboratory ,Israeli Technion Research ,Vice Dean ,Deputy Director ,Lower Saxony Institute ,German Dermatological ,Secretary General ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Trade Show News ,